Arrow International
This article was originally published in The Gray Sheet
Executive Summary
Purchase of the global intra-aortic balloon catheter and pump business of C.R. Bard is completed ("The Gray Sheet" Aug. 18, p. 7). The Reading, Pennsylvania-based firm expects the transaction to be accretive to fiscal year 1999 earnings. However, a pretax charge to income of about $7 mil. is expected in the second quarter (ending Feb. 28) related to in-process R&D. The after tax charge will be approximately $4.5 mil. or 19 cents per share, the firm says